Lipitor’s U.K. Exclusivity Affirmed In Appellate Decision
This article was originally published in The Pink Sheet Daily
Executive Summary
Ranbaxy’s generic atorvastatin may not launch in the U.K. until November 2011, Pfizer says.
You may also be interested in...
Lipitor Generics Could Come 15 Months Earlier Than Anticipated After Patent Deemed Invalid
Pfizer says “technical defect” in patent could be corrected with U.S. Patent and Trademark Office.
Lipitor Generics Could Come 15 Months Earlier Than Anticipated After Patent Deemed Invalid
Pfizer says “technical defect” in patent could be corrected with U.S. Patent and Trademark Office.
Lipitor Is Pound-Wise Versus Generic Zocor, Pfizer IDEAL Cost Study Says
When total healthcare costs are considered, atorvastatin is more cost-effective than simvastatin even when Zocor is discounted 50% from its current price, Pfizer analysis says.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: